DK130477B - Fremgangsmåde til fremstilling af proteaseinhibitor plasminostreptin. - Google Patents

Fremgangsmåde til fremstilling af proteaseinhibitor plasminostreptin.

Info

Publication number
DK130477B
DK130477B DK67973AA DK67973A DK130477B DK 130477 B DK130477 B DK 130477B DK 67973A A DK67973A A DK 67973AA DK 67973 A DK67973 A DK 67973A DK 130477 B DK130477 B DK 130477B
Authority
DK
Denmark
Prior art keywords
plasminostreptin
preparation
protease inhibitor
protease
inhibitor
Prior art date
Application number
DK67973AA
Other languages
Danish (da)
English (en)
Other versions
DK130477C (sh
Inventor
A Kakinuma
H Sugino
N Moriya
M Isono
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK130477B publication Critical patent/DK130477B/da
Application granted granted Critical
Publication of DK130477C publication Critical patent/DK130477C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8142—Aspartate protease (E.C. 3.4.23) inhibitors, e.g. HIV protease inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK67973AA 1972-02-08 1973-02-08 Fremgangsmåde til fremstilling af proteaseinhibitor plasminostreptin. DK130477B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1413272A JPS5434837B2 (sh) 1972-02-08 1972-02-08

Publications (2)

Publication Number Publication Date
DK130477B true DK130477B (da) 1975-02-24
DK130477C DK130477C (sh) 1975-07-28

Family

ID=11852593

Family Applications (1)

Application Number Title Priority Date Filing Date
DK67973AA DK130477B (da) 1972-02-08 1973-02-08 Fremgangsmåde til fremstilling af proteaseinhibitor plasminostreptin.

Country Status (12)

Country Link
US (1) US4014860A (sh)
JP (1) JPS5434837B2 (sh)
BE (1) BE794975A (sh)
CA (1) CA994692A (sh)
CH (1) CH575467A5 (sh)
DE (1) DE2304780A1 (sh)
DK (1) DK130477B (sh)
FR (1) FR2181710B1 (sh)
GB (1) GB1414696A (sh)
NL (1) NL7301822A (sh)
NO (1) NO136204C (sh)
SE (1) SE390543B (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5941718B2 (ja) * 1980-01-31 1984-10-09 エスエス製薬株式会社 新規物質ｍ−９３３７およびその製造法
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
JPS6138212A (ja) * 1984-07-30 1986-02-24 Aisin Warner Ltd 回転部材支持装置
DE3751131T2 (de) * 1986-08-18 1995-07-06 Smithkline Beckman Corp Proteinartiger Proteaseinhibitor aus Streptomyces.
US5279939A (en) * 1986-08-18 1994-01-18 Smithkline Beecham Corporation Protein protease inhibitors from streptomyces
EP0624642B1 (en) * 1993-05-12 1999-01-20 Indian Council For Medical Research Novel thrombolytic agent, process for preparing same and its use for the preparation of a thrombi dissolving medicament

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740319A (en) * 1969-06-13 1973-06-19 Microbial Chem Res Found Biologically active substance,pepstatin and production processes thereof

Also Published As

Publication number Publication date
USB328077I5 (sh) 1976-04-13
FR2181710A1 (sh) 1973-12-07
CA994692A (en) 1976-08-10
GB1414696A (en) 1975-11-19
DE2304780A1 (de) 1973-08-09
NO136204B (sh) 1977-04-25
NO136204C (no) 1977-08-03
CH575467A5 (sh) 1976-05-14
JPS5434837B2 (sh) 1979-10-29
DK130477C (sh) 1975-07-28
US4014860A (en) 1977-03-29
FR2181710B1 (sh) 1976-07-02
BE794975A (fr) 1973-05-29
SE390543B (sv) 1976-12-27
NL7301822A (sh) 1973-08-10
JPS4882089A (sh) 1973-11-02

Similar Documents

Publication Publication Date Title
DK138951B (da) Fremgangsmåde til fremstilling af N-phosphonomethyl-glycin.
DK137329B (da) Analogifremgangsmåde til fremstilling af 2-karbalkoksyaminobenzimidazolderivater.
DK135775B (da) Analogifremgangsmåde til fremstilling af mættede 3alfa-hydroxy-5alfa-pregnaner.
DK138903B (da) Fremgangsmåde til fremstilling af proteolytiske enzymer.
DK130227B (da) Fremgangsmåde til fremstilling af saccharaseinhibitorer.
DK134604B (da) Fremgangsmåde til fremstilling af indenyl-3-acetoglucuronider.
DK138317B (da) Analogifremgangsmåde til fremstilling af cyklohexenonderivater.
DK129088B (da) Fremgangsmåde til fremstilling af peptider.
DK138796B (da) Analogifremgangsmåde til fremstilling af 2-carboxypyrazin-4-oxidderivater.
DK138230B (da) Analogifremgangsmåde til fremstilling af vincanolsalte.
DK130477B (da) Fremgangsmåde til fremstilling af proteaseinhibitor plasminostreptin.
DK138898B (da) Fremgangsmåde til fremstilling af N-phosphonomethylglycin.
DK131864B (da) Fremgangsmåde til fremstilling af pregnan-21-syrederivater.
DK132233B (da) Fremgangsmåde til fremstilling af antibiotikum A-2315.
DK131575B (da) Analogifremgangsmåde til fremstilling af 2beta-hydroxy-3alfa-aminosteroider.
DK138645B (da) Analogifremgangsmåde til fremstilling af sulfamoylfenyl-imidazolidiner.
DK135122B (da) Analogifremgangsmåde til fremstilling af 4-aryl-5-aminoalkyl-4-oxazolin-2-onderivater.
DK135166B (da) Analogifremgangsmåde til fremstilling af 2-methyl-5-nitro-imidazoler.
DK129657B (da) Analogifremgangsmåde til fremstilling af 3-methylpyrazol-5-carboxamider.
DK131579B (da) Fremgangsmåde til fremstilling af en amylaseinhibitor.
DK139677B (da) Fremgangsmåde til fremstilling af 7-benzoylindolin-2-oner.
DK134236B (da) Analogifremgangsmåde til fremstilling af 3-cycloalkoxy-16alfa-cyanopregn-5-en-20-oner.
DK132410B (da) Analogifremgangsmåde til fremstilling af 2-amino-4H-pyraner.
DK129530B (da) Fremgangsmåde til fremstilling af saccharaseinhibitorer.
DK136164B (da) Fremgangsmåde til fremstilling af streptokinase.